Occult Hepatitis C Virus Infection in Hemodialysis Patients
Single Center Study
Keywords:
hepatitis C, hemodialysis, occult infectionAbstract
Introduction: A new form of hepatitis C virus infection, known as occult hepatitis C virus (HCV) infection, is characterized by the presence of HCV_RNA in the liver or peripheral blood mononuclear cells (PBMCs). However, no serological markers of infection occur and there is not as much damage to the liver damage as is produced by chronic hepatitis C. There is a high incidence of HCV infection among hemodialysis patients, there is significant concern about viral transmission. HCV infection is a major problem in hemodialysis (HD) units even though blood products are screened for anti-HCV antibodies and other precautions are taken. The aim of this study was to determine the prevalence of occult HCV infection in PBMC in chronic hemodialysis (CHD) patients in the dialysis unit at Theodor Bilharz Research Institute (TBRI) with HCV antibodies and HCV RNA negativity irrespective of their liver function tests.
Methods: Fifty-three patients who were repeatedly were anti-HCV negative and serum HCV-RNA negative and on regular hemodialysis for > six months were enrolled in the study, which was conducted in the dialysis unit of Nephrology Department at TBRI; there were 10 healthy matched controls. The patients were classified into two groups according to the result HCV RNA in their PBMCs. Serological markers of HCV infection, including anti-HCV antibody and serum HCV-RNA, were repeatedly negative for all patients included in the study. We collected serum and PBMC samples from the patients on the day they entered the study. The test of all serum samples for anti-HCV antibodies and HCV-RNA was repeated by RT-PCR to ensure that the patients did not have these HCV serologic markers, We also measured their ALT and GGT levels.
Results: Occult hepatitis C virus infection (OCI) was detected in 15.1% of our CHD patients without any evidence of chronic liver disease.
Conclusion: Occult HCV infection was present among the hemodialysis patients irrespective of whether they had persistent abnormal values of liver enzymes for which no cause had been identified. Further study is required to determine the clinical significance of occult HCV infections in these patients.
References
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus
infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57:1333-42.
doi: 10.1002/hep.26141, PMID: 23172780.
Moyer VA. Screening for hepatitis C virus infection in adults: u.s. preventive services task force
recommendation statement. Ann Intern Med. 2013;159: 349–57. doi: 10.7326/0003-4819-159-5- 201309030-00672, PMID: 23798026.
Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroentrol. 2007; 7;13(17): 2436-41. doi:
3748/wjg.v13.i17.2436.
Reker C, Islam KM. Risk factors associated with high prevalence rate of hepatits C infection in Egypt. Int
J Infect Dis. 2014; 25: 104-6. doi: 10.1016/j.ijid.2014.02.003, PMID: 24865321.
Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis.
; 5: 558-67. doi: 10.1016/S1473-3099(05)70216-4.
Jou JH, Muir AJ. In the clinic. Hepatitis C. Ann Intern Med. 2012; 157, ITC6-1- ITC6-16. doi:
7326/0003-4819-157-11-20121204-01006, PMID: 23208180.
Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, et al. Occult hepatitis C
virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is
unknown. J Infect Dis. 2004;189: 7–14. doi: 10.1086/380202, PMID: 14702147.
Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Pardo M, Bartolome J, Carreno V. Hepatitis C virus
replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis.
; 43: 1277-83. doi: 10.1086/508198, PMID: 17051492.
Baid-Agrawal S, Schindler R, Reinke P, Staedtler A, Rimpler S, Malik B, et al. Prevalence of occult
hepatitis C infection in chronic hemodialysis and kidney transplant patients. J Hepatol. 2014; 60: 928-33.
doi: 10.1016/j.jhep.2014.01.012, PMID: 24447875.
Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia- Fernandez N, et al. Occult
hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008;19: 2288-92. doi:
1681/ASN.2008030293, PMID: 18684893 , PMCID: PMC2588096.
Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral
blood mononuclear cells. Immunol Invest. 2010; 39: 284-91. doi: 10.3109/08820131003605820, PMID:
Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009; 49:
–75. doi: 10.1002/hep.22706, PMID: 19105211.
Pham TN, Coffin CS, Michalak TI. Occult hepatitis C virus infection: what does it mean? Liver Int. 2010;
: 502–11. doi: 10.1111/j.1478-3231.2009.02193.x, PMID: 20070513.
De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D, et al. Occult HCV infection: an
unexpected finding in a population unselected for hepatic disease. PLoS One. 2009; 4: e8128. doi:
1371/journal.pone.0008128, PMID: 19956542, PMCID: PMC2780719.
De Marco L, Manzini P, Trevisan M, Gillio-Tos A, Danielle F, Balloco C, et al. Prevalence and follow-up
of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS
One 2012; 7: e43541. doi: 10.1371/journal.pone.0043541, PMID: 22927986 , PMCID: PMC3425488.
Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, deGiacomo M, et al. Negative-strand
hepatitis C virus (HCV) RNA in prepheral blood mononuclear cells from anti-HCV-positive/HIV infected
women. J Infect Dis. 2007; 195(1): 124-33. doi: 10.1086/509897 , PMID: 17152016, PMCID:
PMC3319123.
Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, et al. Characteristics and causes of
immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008; 28: S183–7. PMID: 18552253.
Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection
on survival in dialysis patients: Meta-analysis of observational studies. J Viral Hepat. 2007; 14: 697–703.
doi: 10.1111/j.1365-2893.2007.00868.x, PMID: 17875004.
Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult Hepatitis C
Virus Infection in Iranian Patients With Cryptogenic Liver Disease. J Med Virol. 2011; 83: 989–95. doi:
1002/jmv.22044, PMID: 21503911.
Thongsawat S, Maneekarn N, Kuniholm MH, Pantip C, Thungsuputi A, Lumlertkul D, et al. Occult
hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand. J Med Virol. 2008; 80:
–15. doi: 10.1002/jmv.21126, PMID: 18360894.
Fabrizi F, Martin P. Occult hepatitis C virus infection in hemodialysis. J Am Soc Nephrol. 2008; 19:2248–
doi: 10.1681/ASN.2008101051, PMID: 19020002.
Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sunder-Plassmann G, Petermann D, et al. HBV and HCV
genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int.
; 48: 1967–71. doi: 10.1038/ki.1995.498, PMID: 8587259.
Jadoul M, Cornu C, van Ypersele de Strihou C: Universal precautions prevent hepatitis C virus
transmission: A 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc
(UCL) Collaborative Group. Kidney Int.1998; 53: 1022–25. doi: 10.1111/j.1523-1755.1998.00823.x,
PMID: 9551413.
CarrenoV, Bartolome J, Castillo I, Quiroga JA. New prespective in occult hepatitis C virus infection.
World J Gastroenterol. 2012: 18(23); 2887-94. doi: 10.3748/wjg.v18.i23.2887, PMID: 22736911, PMCID:
PMC3380315.
Kopkooo PM, Holland PV. Universal leukocyte reduction. Curr Opin Hematol 2000;7:397-401.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
